| Name | Title | Contact Details |
|---|
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
The b.well connected health platform provides an all-in-one integrated solution for consumer engagement, holistic health management, and cost containment. Our use of longitudinal aggregated data creates a complete picture of health for each consumer and is aggregated to allow for true population health management. Our unique approach to partner integration allows our customers to change their programs in real time as the health needs of their population change, not on an annual sales cycle. With the b.well platform there is one contract, one implementation and the elimination of point-solution fatigue. We provide real-time transparent dashboards to all customers highlighting return on investment, cost containment opportunities, engagement metrics and outreach campaign outcomes, clinical risk factors and disease states. b.well supports health plans, health systems, employers and pharmaceutical companies to bring their digital strategy to life and enables them to provide their employees, members and patients with the one thing they do not have today; one place to manage all aspects of their health.
Heyday is a people-first skincare company, bringing together human touch, expertise, and data to personalize and empower people to take care of their skin. We opened our first retail location in 2015 – taking the facial and indulgence out of the spa, elevating the estheticians as the experts they are, and removing the overwhelm out of building an at-home skincare routine. Today, we have 9 locations in New York, Los Angeles, and Philadelphia. We`ve performed 225,000 facials, collected data on skincare conditions, preferences, and purchases, and become an employer of choice for a world-class team of estheticians we call Heyday Skin Therapists. Our next chapter is to take these ingredients and create unparalleled personalization and guidance across content, communities, recommendations, and services in both our physical stores and our e-commerce experience. `Heyday` means a period of your life when you`re feeling at your best. Above all, we exist to help people achieve their `heyday` – to show up in the world as their best selves, every day. We start with the skin you`re in.
F-D-C Reports, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EyeWatch Live is a company that provides a virtual nurse monitoring system that combines artificial intelligence (AI) with human intelligence (HI) to identify unwanted activity and prevent falls before they occur.